Cargando…

Clinicopathological Features Combined With Immune Infiltration Could Well Distinguish Outcomes in Stage II and Stage III Colorectal Cancer: A Retrospective Study

BACKGROUND: The Immunoscore predicts prognosis in patients with colorectal cancer (CRC). However, a few studies have incorporated the Immunoscore into the construction of comprehensive prognostic models in CRC, especially stage II CRC. We aimed to construct and validate multidimensional models integ...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ren, Jiazi, Xu, Linfeng, Zhou, Siyu, Ouyang, Jian, You, Weiqiang, Sheng, Nengquan, Yan, Li, Peng, Du, Xie, Lu, Wang, Zhigang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8678133/ https://www.ncbi.nlm.nih.gov/pubmed/34926285 http://dx.doi.org/10.3389/fonc.2021.776997

Ejemplares similares

Construction and Validation of Convenient Clinicopathologic Signatures for Predicting the Prognosis of Stage I-III Gastric Cancer
por: You, Weiqiang, et al.
Publicado: (2022)

The difference in prognosis of stage II and III colorectal cancer based on preoperative serum tumor markers
por: You, Weiqiang, et al.
Publicado: (2019)

Clinical Significances of Positive Postoperative Serum CEA and Post-preoperative CEA Increment in Stage II and III Colorectal Cancer: A Multicenter Retrospective Study
por: You, Weiqiang, et al.
Publicado: (2020)

Blood cholesterol-to-lymphocyte ratio as a novel prognostic marker to predict postoperative overall survival in patients with colorectal cancer
por: Zhou, Siyu, et al.
Publicado: (2022)

Clinical Significance of and Predictive Risk Factors for the Postoperative Elevation of Carcinoembryonic Antigen in Patients With Non-Metastatic Colorectal Cancer
por: Zhou, Siyu, et al.
Publicado: (2021)

Association of Tumor-Infiltrating Lymphocytes With Survival in Stages II and III Colorectal Cancer
por: Vitorino, Marina, et al.
Publicado: (2022)

Clinicopathologic and endoscopic features of early-stage colorectal serrated adenocarcinoma
por: Hirano, Daiki, et al.
Publicado: (2017)

Evaluation of cell surface vimentin positive circulating tumor cells as a prognostic biomarker for stage III/IV colorectal cancer
por: Cao, Yuepeng, et al.
Publicado: (2023)

Correction: Association of Tumor-Infiltrating Lymphocytes With Survival in Stages II and III Colorectal Cancer
por: Vitorino, Marina, et al.
Publicado: (2023)

Clinicopathologic features of colorectal carcinoma: features predicting higher T-stage and nodal metastasis
por: Hashmi, Atif Ali, et al.
Publicado: (2018)

MiR‐145 inhibits human colorectal cancer cell migration and invasion via PAK4‐dependent pathway
por: Sheng, Nengquan, et al.
Publicado: (2017)

TRIP13 promotes tumor growth and is associated with poor prognosis in colorectal cancer
por: Sheng, Nengquan, et al.
Publicado: (2018)

Analysis of the Clinicopathological Characteristics of Stage I–III Colorectal Cancer Patients Deficient in Mismatch Repair Proteins
por: Liang, Yichao, et al.
Publicado: (2021)

Development and validation of prognostic nomograms based on De Ritis ratio and clinicopathological features for patients with stage II/III colorectal cancer
por: Fu, Jinming, et al.
Publicado: (2023)

Prognostic significance of tumor genotypes and CD8+ infiltrates in stage I-III colorectal cancer
por: Fountzilas, Elena, et al.
Publicado: (2018)

Relative contribution of clinicopathological variables, genomic markers, transcriptomic subtyping and microenvironment features for outcome prediction in stage II/III colorectal cancer
por: Dienstmann, R, et al.
Publicado: (2019)

Clinicopathological Features and Oncological Outcomes of Early and Late Recurrence in Stage III Colorectal Cancer Patients after Adjuvant Oxaliplatin-Based Therapy
por: Chang, Yu-Tang, et al.
Publicado: (2023)

Molecular alterations in clinical stage III cutaneous melanoma: Correlation with clinicopathological features and patient outcome
por: RUTKOWSKI, PIOTR, et al.
Publicado: (2014)

Different clinicopathologic features and favorable outcomes of patients with stage III left-sided colon cancer
por: Huang, Ching-Wen, et al.
Publicado: (2015)

Serum metabolomic profile as a means to distinguish stage of colorectal cancer
por: Farshidfar, Farshad, et al.
Publicado: (2012)

Clinicopathological Features of Early-Stage Esophageal Carcinosarcoma
por: Kubo, Kentaro, et al.
Publicado: (2022)

Clinicopathologic Significance of Survivin Expression in Relation to CD133 Expression in Surgically Resected Stage II or III Colorectal Cancer
por: Li, Wanlu, et al.
Publicado: (2017)

Commentary: The oral microbiome in young women at different stages of periodontitis: Prevotella dominant in stage III periodontitis
por: Huang, Weiqiang, et al.
Publicado: (2023)

Survival nomograms for stage III colorectal cancer
por: Li, Chenglong, et al.
Publicado: (2018)

Interface topology for distinguishing stages of sintering
por: Okuma, Gaku, et al.
Publicado: (2017)

Tumour-infiltrating CD68+ and CD57+ cells predict patient outcome in stage II–III colorectal cancer
por: Chaput, N, et al.
Publicado: (2013)

Prognostic Factors Influencing Survival in Stage II and Stage III Colorectal Cancer Patients
por: Alkader, Mohammad S, et al.
Publicado: (2023)

Patterns of Sociodemographic and Clinicopathologic Characteristics of Stages II and III Colorectal Cancer Patients by Age: Examining Potential Mechanisms of Young-Onset Disease
por: Murphy, Caitlin C., et al.
Publicado: (2017)

Clinicopathologic implications of immune classification by PD-L1 expression and CD8-positive tumor-infiltrating lymphocytes in stage II and III gastric cancer patients
por: Koh, Jiwon, et al.
Publicado: (2017)

Development and validation of postoperative circulating tumor DNA combined with clinicopathological risk factors for recurrence prediction in patients with stage I-III colorectal cancer
por: Gao, Zhaoya, et al.
Publicado: (2023)

Thymidine Phosphorylase Gene Expression in Stage III Colorectal Cancer
por: Lindskog, Elinor B., et al.
Publicado: (2012)

Role of Bruton’s Tyrosine Kinase in Stage III Colorectal Cancer
por: Basile, Debora, et al.
Publicado: (2019)

Optimal postoperative surveillance strategies for stage III colorectal cancer
por: Park, Min Young, et al.
Publicado: (2021)

Clinicopathologic Factors Affecting Recurrence after Curative Surgery for Stage I Colorectal Cancer
por: Keum, Min Ae, et al.
Publicado: (2012)

Sub-classification of Stage II colorectal cancer based on clinicopathological risk factors for recurrence
por: Hashimoto, Takuzo, et al.
Publicado: (2013)

High Infiltration of CD203c(+) Mast Cells Reflects Immunosuppression and Hinders Prognostic Benefit in Stage II-III Colorectal Cancer
por: Li, Jing, et al.
Publicado: (2023)

Mapk14 is a Prognostic Biomarker and Correlates with the Clinicopathological Features and Immune Infiltration of Colorectal Cancer
por: Wang, Dan, et al.
Publicado: (2022)

Establishment and validation of a novel nomogram incorporating clinicopathological parameters into the TNM staging system to predict prognosis for stage II colorectal cancer
por: Mo, Shaobo, et al.
Publicado: (2020)

Serum fibronectin distinguishes the early stages of hepatocellular carcinoma
por: Kim, Hyunsoo, et al.
Publicado: (2017)

Clinical Significance of Lymph Node Ratio in Stage III Colorectal Cancer
por: Park, Yo Han, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_48ot2sptrsukie24jv9tk443s4